NCT07734311 clinical trial report covering Ecnoglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07733947 clinical trial report covering Resveratrol/Curcumin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07734844 clinical trial report covering Tabirafusp alfa tedromer, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07734155 clinical trial report covering Levonorgestrel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07736313 clinical trial report covering Rosuvastatin Calcium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738068 clinical trial report covering Progesterone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07737262 clinical trial report covering Acetylcysteine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07735637 clinical trial report covering Lenalidomide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

AAVantgarde Bio, Corp USA BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

NCT07737964 clinical trial report covering Acetazolamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262937 clinical trial report covering Bempedoic acid/Ezetimibe, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07739368 clinical trial report covering Ferric Maltol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.